Mmastodon HealthHealth first seen 10 h ago, last 35 min ago, peak #1
Clues Emerge on Why Pancreatic Cancer Drug Stops Working
Original: Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working https://www.nytimes.com/2026/09/30/science/p
New reporting examines why daraxonrasib, a breakthrough drug for pancreatic cancer, eventually stops working in patients. Researchers have identified clues about the resistance mechanisms that develop over time, a step that could guide combination treatments and extend the drug's effectiveness for one of the deadliest cancers.
Why now: Fresh research on drug resistance in a promising pancreatic cancer treatment has drawn attention from clinicians, patients and science readers.
daraxonrasibpancreatic cancerNew York Times
Rank over time, top of the chart is #1. 20 snapshots from 10 h ago to 35 min ago.
Evidence
- Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working https://www.nytimes.com/2026/09/30/science/pancreatic-cancer-drug-daraxonrasib-ben-sasse-resistance.html # Science # Health # Medicine · nyt_politics@robot.villas · 2
API: https://socialmediatrends-api.osmike.com/v1/trends/515240